Drug Side Effects
Search
SPEECH LATENCY
SPEECH LATENCY
was reported 0 times
SPEECH LATENCY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Interleukin-5 Antagonist [EPC]
1
0.0015
1
CD38-directed Cytolytic Antibody [EPC]
3
0.0005
2
Nonergot Dopamine Agonist [EPC]
3
0.0002
3
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
1
0.0001
4
Hedgehog Pathway Inhibitor [EPC]
1
0.0001
5
Human Immunoglobulin G [EPC]
2
0.0001
6
Androgen [EPC]
1
0.0000
7
Anti-epileptic Agent [EPC]
6
0.0000
8
Mood Stabilizer [EPC]
5
0.0000
9
Atypical Antipsychotic [EPC]
10
0.0000
10
Topoisomerase Inhibitor [EPC]
1
0.0000
11
Catecholamine [EPC]
1
0.0000
12
Benzodiazepine [EPC]
8
0.0000
13
Opioid Agonist [EPC]
3
0.0000
14
Proteasome Inhibitor [EPC]
1
0.0000
15
Alkylating Drug [EPC]
2
0.0000
16
Serotonin-3 Receptor Antagonist [EPC]
1
0.0000
17
alpha-Adrenergic Blocker [EPC]
1
0.0000
18
Thalidomide Analog [EPC]
3
0.0000
19
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
20
Nonsteroidal Anti-inflammatory Drug [EPC]
5
0.0000
21
Platelet Aggregation Inhibitor [EPC]
2
0.0000
22
beta-Adrenergic Blocker [EPC]
1
0.0000
23
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
24
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
25
Corticosteroid [EPC]
4
0.0000
26
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
27
GLP-1 Receptor Agonist [EPC]
1
0.0000
28
Proton Pump Inhibitor [EPC]
1
0.0000